期刊文献+

硝酸酯类一氧化氮供体药物研究进展 被引量:8

Development of nitrate NO-releasing agents
原文传递
导出
摘要 一氧化氮(nitric oxide,NO)具有多种生理活性,为了使经典药物发挥更广泛或者更好的治疗作用,研究人员将能释放NO的硝酸酯类基团与这些药物骈合,得到了一系新型硝酸酯类供体药物。这些药物涉及解热镇痛药、非甾体抗炎药、循环系统药和化学治疗药等。这类药物在体内被分解为母体药物和NO,二者分别发挥生理效应,达到协同增效作用。过去几年里,新型硝酸酯类NO供体药物受到了广泛研究,并取得了一些成果。文中综述了这类药物近年来的研究进展。 The physiological activity of nitric oxide (NO) is very extensive. For the purpose of developing more comprehensive or satisfactory therapy, these drugs are conjugated with the groups releasing NO, and a series of novel nitrate NO-releasing drugs have been obtained. Related classic drugs include antipyretic analgesics, non- steroidal anti-inflammatory drugs, circulator), system drugs, and chemotherapeutic drugs. The new conjugated NO- releasing drugs are degraded into parent drug and NO in vivo. Both of them play their pharmacological effects to achieve synergy. During the past several years, this kind of new agents has been researched broadly, and some of them have succeeded. In this article, we reviewed the development of novel nitrate NO-releasing agents in recent years.
作者 罗刚 陈宇瑛
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第15期1322-1328,共7页 Chinese Journal of New Drugs
关键词 一氧化氮 硝酸酯类 供体药物 nitric oxide nitrates donating agents
  • 相关文献

参考文献30

  • 1STUEHR DJ, KWON NS, NATHAN CF, et al. NW-Hydroxy-L- arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine[J]. JBiol Chem, 1991, 26(10): 6259-6263.
  • 2RAO CV, REDDY BS, STEELE VE, et al. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects an molecular targets [J]. Mol Cancer Ther, 2006, 5(6) :1530-1538.
  • 3WALLACE JL, MUSCARA MN, DE NUCCI G, et al. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [ 3 - [ 4- ( 2 -Fluoro-α-methyl- [ 1, 1'-biphenyl ] -4-acetyloxy ) -3 -methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester I [J ]. J Pharmacol Exp Ther, 2004, 309 (2) :626 - 633.
  • 4BERNARDO A, GASPARINI L, ONGINI E, et al. Dynamic reg- ulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216 : implications for chronic treatments of neurodegenerative diseases [ J ]. Neurobiol Dis, 2006, 22 ( 1 ) :25 - 32.
  • 5BRUNELI,I S, SCIORATI C, D'ANTONA G, et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy[J]. Proc Natl Acad Sci USA, 2007, 104(1) :264 -269.
  • 6ABDUL-HAY SO, LUO J, ASHGHODOM RT, et al. NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade [ J ]. J Neurochem, 2009, 111 (3) :766 -776.
  • 7KARLSSON J, PIVODIC A, AGUIRRE D, et al. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee [J]. J Rheumatol, 2009, 36(6):1290-1297.
  • 8WHITE WB, SCHNITZER TJ, FLEMING R, et al. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis[J]. Am J Cardiol, 2009, 104(6) :840 -845.
  • 9CURROS-CRIADO MM, HERRERO JF. Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin[ J]. Br J Pharmacol, 2009, 158(2) :601 -609.
  • 10ROMERO-SANDOVAL EA, CURROS-CRIADO MM, GAITAN G, et al. Nitroparacetamol ( NCX-701 ) and pain : first in a series of novel analgesics [ J ]. CNS Drug Reviews, 2007, 13 (3) : 279 - 295.

同被引文献65

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部